These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10528237)

  • 1. MET(PRC) mutations in the Ron receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential.
    Williams TA; Longati P; Pugliese L; Gual P; Bardelli A; Michieli P
    J Cell Physiol; 1999 Dec; 181(3):507-14. PubMed ID: 10528237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between the proto-oncogenes Met and Ron.
    Follenzi A; Bakovic S; Gual P; Stella MC; Longati P; Comoglio PM
    Oncogene; 2000 Jun; 19(27):3041-9. PubMed ID: 10871856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor.
    Santoro MM; Penengo L; Minetto M; Orecchia S; Cilli M; Gaudino G
    Oncogene; 1998 Aug; 17(6):741-9. PubMed ID: 9715276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis.
    Peace BE; Hughes MJ; Degen SJ; Waltz SE
    Oncogene; 2001 Sep; 20(43):6142-51. PubMed ID: 11593422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutations of the MET proto-oncogene in papillary renal carcinomas.
    Schmidt L; Junker K; Nakaigawa N; Kinjerski T; Weirich G; Miller M; Lubensky I; Neumann HP; Brauch H; Decker J; Vocke C; Brown JA; Jenkins R; Richard S; Bergerheim U; Gerrard B; Dean M; Linehan WM; Zbar B
    Oncogene; 1999 Apr; 18(14):2343-50. PubMed ID: 10327054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway.
    Danilkovitch-Miagkova A; Miagkov A; Skeel A; Nakaigawa N; Zbar B; Leonard EJ
    Mol Cell Biol; 2001 Sep; 21(17):5857-68. PubMed ID: 11486025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.
    Iwama A; Yamaguchi N; Suda T
    EMBO J; 1996 Nov; 15(21):5866-75. PubMed ID: 8918464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential.
    Zhou YQ; He C; Chen YQ; Wang D; Wang MH
    Oncogene; 2003 Jan; 22(2):186-97. PubMed ID: 12527888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase.
    Rodrigues GA; Park M
    Oncogene; 1994 Jul; 9(7):2019-27. PubMed ID: 8208547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth.
    Bardelli A; Longati P; Gramaglia D; Basilico C; Tamagnone L; Giordano S; Ballinari D; Michieli P; Comoglio PM
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14379-83. PubMed ID: 9826708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ron kinase transphosphorylation sustains MET oncogene addiction.
    Benvenuti S; Lazzari L; Arnesano A; Li Chiavi G; Gentile A; Comoglio PM
    Cancer Res; 2011 Mar; 71(5):1945-55. PubMed ID: 21212418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive activation of the RON gene promotes invasive growth but not transformation.
    Santoro MM; Collesi C; Grisendi S; Gaudino G; Comoglio PM
    Mol Cell Biol; 1996 Dec; 16(12):7072-83. PubMed ID: 8943362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling requirements for oncogenic forms of the Met tyrosine kinase receptor.
    Jeffers M; Koochekpour S; Fiscella M; Sathyanarayana BK; Vande Woude GF
    Oncogene; 1998 Nov; 17(21):2691-700. PubMed ID: 9840933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the wild-type and Y1235D mutant Met kinase activation.
    Cristiani C; Rusconi L; Perego R; Schiering N; Kalisz HM; Knapp S; Isacchi A
    Biochemistry; 2005 Nov; 44(43):14110-9. PubMed ID: 16245927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines.
    Chen YQ; Zhou YQ; Angeloni D; Kurtz AL; Qiang XZ; Wang MH
    Exp Cell Res; 2000 Nov; 261(1):229-38. PubMed ID: 11082293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness.
    Maggiora P; Lorenzato A; Fracchioli S; Costa B; Castagnaro M; Arisio R; Katsaros D; Massobrio M; Comoglio PM; Flavia Di Renzo M
    Exp Cell Res; 2003 Aug; 288(2):382-9. PubMed ID: 12915129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional domains critical for constitutive activation of the HGF-receptor (Met).
    Zhen Z; Giordano S; Longati P; Medico E; Campiglio M; Comoglio PM
    Oncogene; 1994 Jun; 9(6):1691-7. PubMed ID: 8183564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ron oncogenic activity induced by the MEN2B-like substitution overcomes the requirement for the multifunctional docking site.
    Santoro MM; Penengo L; Orecchia S; Cilli M; Gaudino G
    Oncogene; 2000 Oct; 19(45):5208-11. PubMed ID: 11064459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen-related growth factor and semaphorin receptors: a gene superfamily controlling invasive growth.
    Comoglio PM; Tamagnone L; Boccaccio C
    Exp Cell Res; 1999 Nov; 253(1):88-99. PubMed ID: 10579914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
    Comoglio PM
    EXS; 1993; 65():131-65. PubMed ID: 8380735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.